Literature DB >> 33509241

Incidence and risk factors for deep venous thrombosis of lower extremity after surgical treatment of isolated patella fractures.

Zhanchao Tan1, Hongzhi Hu2, Xiangtian Deng3, Jian Zhu3, Yanbin Zhu1,4, Dandan Ye4, Xiaodong Cheng4, Yingze Zhang5,6.   

Abstract

BACKGROUND: Limited information exists on the incidence of postoperative deep venous thromboembolism (DVT) in patients with isolated patella fractures. The objective of this study was to investigate the postoperative incidence and locations of deep venous thrombosis (DVT) of the lower extremity in patients who underwent isolated patella fractures and identify the associated risk factors.
METHODS: Medical data of 716 hospitalized patients was collected. The patients had acute isolated patella fractures and were admitted at the 3rd Hospital of Hebei Medical University between January 1, 2016, and February 31, 2019. All patients met the inclusion criteria. Medical data was collected using the inpatient record system, which included the patient demographics, patient's bad hobbies, comorbidities, past medical history, fracture and surgery-related factors, hematological biomarkers, total hospital stay, and preoperative stay. Doppler examination was conducted for the diagnosis of DVT. Univariate analyses and multivariate logistic regression analyses were used to identify the independent risk factors.
RESULTS: Among the 716 patients, DVT was confirmed in 29 cases, indicating an incidence of 4.1%. DVT involved bilateral limbs (injured and uninjured) in one patient (3.4%). DVT involved superficial femoral common vein in 1 case (3.4%), popliteal vein in 6 cases (20.7%), posterior tibial vein in 11 cases (37.9%), and peroneal vein in 11 cases (37.9%). The median of the interval between surgery and diagnosis of DVT was 4.0 days (range, 1.0-8.0 days). Six variables were identified to be independent risk factors for DVT which included age category (> 65 years old), OR, 4.44 (1.34-14.71); arrhythmia, OR, 4.41 (1.20-16.15); intra-operative blood loss, OR, 1.01 (1.00-1.02); preoperative stay (delay of each day), OR, 1.43 (1.15-1.78); surgical duration, OR, 1.04 (1.03-1.06); LDL-C (> 3.37 mmol/L), OR, 2.98 (1.14-7.76).
CONCLUSION: Incidence of postoperative DVT in patients with isolated patella fractures is substantial. More attentions should be paid on postoperative DVT prophylaxis in patients with isolated patella fractures. Identification of associated risk factors can help clinicians recognize the risk population, assess the risk of DVT, and develop personalized prophylaxis strategies.

Entities:  

Keywords:  DVT; Patella fractures; Risk factors

Mesh:

Year:  2021        PMID: 33509241      PMCID: PMC7844981          DOI: 10.1186/s13018-021-02240-9

Source DB:  PubMed          Journal:  J Orthop Surg Res        ISSN: 1749-799X            Impact factor:   2.359


  30 in total

1.  Delayed surgery for patients with femur and hip fractures-risk of deep venous thrombosis.

Authors:  Eric B Smith; Javad Parvizi; James J Purtill
Journal:  J Trauma       Date:  2011-06

2.  The incidence of thromboembolic events in surgically treated ankle fracture.

Authors:  Stéphane Pelet; Marie-Eve Roger; Etienne L Belzile; Marc Bouchard
Journal:  J Bone Joint Surg Am       Date:  2012-03-21       Impact factor: 5.284

3.  Early outcome after isolated calf vein thrombosis.

Authors:  M H Meissner; M T Caps; R O Bergelin; R A Manzo; D E Strandness
Journal:  J Vasc Surg       Date:  1997-11       Impact factor: 4.268

Review 4.  Chemoprophylaxis for Venous Thromboembolism in Operative Treatment of Fractures of the Tibia and Distal Bones: A Systematic Review and Meta-analysis.

Authors:  Joseph T Patterson; Saam Morshed
Journal:  J Orthop Trauma       Date:  2017-09       Impact factor: 2.512

5.  A prospective study of venous thromboembolism after major trauma.

Authors:  W H Geerts; K I Code; R M Jay; E Chen; J P Szalai
Journal:  N Engl J Med       Date:  1994-12-15       Impact factor: 91.245

6.  Lower extremity calf thrombosis: to treat or not to treat?

Authors:  J M Lohr; T M Kerr; K S Lutter; R D Cranley; K Spirtoff; J J Cranley
Journal:  J Vasc Surg       Date:  1991-11       Impact factor: 4.268

Review 7.  Incidence and risk factors for venous thromboembolism following surgical treatment of fractures below the hip: a meta-analysis.

Authors:  Lei Tan; Baochang Qi; Tiecheng Yu; Chengxue Wang
Journal:  Int Wound J       Date:  2016-03-02       Impact factor: 3.315

8.  Socioeconomic factors and individual lifestyles influencing the incidence of patella fractures: a national population-based survey in China.

Authors:  Yanbin Zhu; Song Liu; Wei Chen; Lin Wang; Xiaolin Zhang; Yingze Zhang
Journal:  Int Orthop       Date:  2018-05-19       Impact factor: 3.075

9.  Warfarin sodium in prevention of deep venous thrombosis and pulmonary embolism in patients with fractured neck of femur.

Authors:  G K Morris; J R Mitchell
Journal:  Lancet       Date:  1976-10-23       Impact factor: 79.321

10.  Hyperlipidemia: a novel etiologic factor in deep vein thrombosis.

Authors:  T Kawasaki; J Kambayashi; M Sakon
Journal:  Thromb Res       Date:  1995-07-15       Impact factor: 3.944

View more
  3 in total

Review 1.  Characteristics of Deep Venous Thrombosis in Isolated Lower Extremity Fractures and Unsolved Problems in Guidelines: A Review of Recent Literature.

Authors:  Wei-Guang Zhao; Wei-Li Zhang; Ying-Ze Zhang
Journal:  Orthop Surg       Date:  2022-05-27       Impact factor: 2.279

2.  Perioperative red blood cell infusion and deep vein thrombosis in patients with femoral and pelvic fractures: a propensity score matching.

Authors:  Linqin Wu; Bo Cheng
Journal:  J Orthop Surg Res       Date:  2021-06-05       Impact factor: 2.359

3.  The Perioperative Deep Vein Thrombosis in Lower Extremities in Patients With Pelvic Fracture: A Case-Control Study.

Authors:  Yun Yan; Baobao Zhang; Jie Yang; Yan Zhang; Lei Zhang; Dan Wang; Jing Gao; Lianzhi He; Pengfei Wang; Yan Zhuang; Kun Zhang; Ping Liu
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.